Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06234995 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cortical Electrophysiology of Response Inhibition in Parkinson's Disease

StatusRecruiting
PhasePhase 4
Started2021-08-09
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 13 months later Jul 2026 → Sep 2027
See other at-risk trials from Emory University

Amendment history

2026-09-01
Study Status v3
Primary completion pushed: 2026-07 → 2027-09
Completion pushed: 2026-07 → 2027-09
2026-03-24
Study Identification, Study Status, Oversight, Arms and Interventions, Document Section v2
Primary completion date2026-07-31→2026-07
Completion date2026-07-31→2026-07
2025-03-06
Study Status, Oversight, Eligibility v1
Eligibility criteria+40 characters
[...] tiparkinsonian medications for research recordings dementia non-English speaker Inclusion Criteria for Persons with Parkinson's Disease for [...] tric disorder and/or treatment with psychotropic medications non-English speaker
2024-01-23
Original filing
Patients with Parkinson's Disease will be studied before, during, and after a deep brain stimulation implantation procedure to see if the stimulation location and the size of the electrical field produced by subthalamic nucleus (STN) DBS determine the degree to which DBS engages circuits that involve prefrontal cortex executive functions, and therefore have a direct impact on the patient's ability to inhibit actions.
Trial Details
NCT Number NCT06234995
Lead Sponsor Emory University
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Conditions Parkinson Disease
Enrollment 80 participants
Start Date 2021-08-09
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-09-03